新型生物标志物可溶性髓样细胞触发受体-1在重症肺炎早期诊断中的应用价值

doi:10.3877/cma.j.issn.1674-1358.2022.05.004

中华实验和临床感染病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 307 -312. doi: 10.3877/cma.j.issn.1674-1358.2022.05.004

论著

新型生物标志物可溶性髓样细胞触发受体-1在重症肺炎早期诊断中的应用价值

贺雨¹, 王玉娟², 高蓉¹, 李晗¹, 胡长英¹, 杨俊玲¹^,^†(

)

^1. 130041　长春市，吉林大学第二医院呼吸与危重症医学科
^2. 710000　西安市，西安交通大学第二附属医院呼吸与危重症医学科

收稿日期:2021-10-20 出版日期:2022-10-15
通信作者: 杨俊玲
基金资助:
吉林省财政厅卫生专项项目(No. 2020SC2T005); 吴阶平医学基金会临床科研专项资助基金项目(No. 320.6750.2021-23-23)

Clinical value of a new biomarker serum soluble myeloid cell triggered receptor-1 in early diagnosis of severe pneumonia

Yu He¹, Yujuan Wang², Rong Gao¹, Han Li¹, Changying Hu¹, Junling Yang¹^,^†()

^1. Department of Pulmonary and Critical Care Medicine, The Second Hospital of Jilin University, Changchun 130041, China
^2. Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, China

Received:2021-10-20 Published:2022-10-15
Corresponding author: Junling Yang

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

贺雨, 王玉娟, 高蓉, 李晗, 胡长英, 杨俊玲. 新型生物标志物可溶性髓样细胞触发受体-1在重症肺炎早期诊断中的应用价值[J/OL]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 307-312.

Yu He, Yujuan Wang, Rong Gao, Han Li, Changying Hu, Junling Yang. Clinical value of a new biomarker serum soluble myeloid cell triggered receptor-1 in early diagnosis of severe pneumonia[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(05): 307-312.

目的

探究血清可溶性髓样细胞触发受体-1（sTREM-1）在重症肺炎早期诊断中的应用价值。

方法

2021年6月到2021年12月于吉林大学第二医院就诊的60例肺炎患者纳入研究组，其中重症40例（重症肺炎组）和轻症20例（普通肺炎组）。以及同期门诊体检者15例纳入健康对照组。研究组患者均于入院24 h内使用肺炎严重程度指数（PSI）评分进行评估；分别采用电化学发光法、散射比浊法、酶联免疫吸附实验（ELISA）检测血清降钙素原（PCT）、超敏C-反应蛋白（hs-CRP）和sTREM-1水平。比较重症肺炎组、普通肺炎组及健康对照组研究对象入组24 h内血清sTREM-1水平，并比较重症肺炎组和普通肺炎组研究对象入组24 h内血清PCT、hs-CRP水平及PSI评分。采用Pearson相关性分析探讨血清sTREM-1和hs-CRP水平与PSI评分的相关性；采用Spearson相关性探讨血清PCT水平与PSI评分的相关性。绘制受试者工作特征曲线（ROC）及应用MedCalc软件比较曲线下面积（AUC）比较血清sTREM-1、PCT和hs-CRP对重症肺炎早期诊断的价值。

结果

重症肺炎组、普通肺炎组以及健康对照组血清sTREM-1表达水平（4 864.81 ± 1 314.53 pg/ml、1 144.58 ± 571.01 pg/ml、509.11 ± 43.70 pg/ml）差异有统计学意义（F = 109.292、P < 0.001），其中重症肺炎组较普通肺炎组和健康对照组显著升高（t = 10.981、P < 0.001，t = 9.264、P < 0.001）。重症肺炎组患者血清PCT、hs-CRP水平以及PSI评分均高于普通肺炎组，差异有统计学意义（Z =－3.360、P = 0.001，t = 2.047、P = 0.048，t = 4.878、P < 0.001）。血清sTREM-1、PCT和hs-CRP诊断重症肺炎的AUC分别为1.00、0.86和0.68（95%CI：1.00~1.00、0.73~0.98、0.51~0.86）；分别以2 916.92 pg/ml、0.31 ng/ml和32.14 mg/L为截断值时约登指数最大，对应的敏感性分别为100%、85%和85%，特异性分别为100%、81%和50%。sTREM-1诊断重症肺炎的AUC与hs-CRP、PCT差异均有统计学意义（Z = 3.463、P < 0.001，Z = 2.220、P = 0.026）；hs-CRP与PCT差异无统计学意义（Z = 1.454、P = 0.146）。PSI评分与血清sTREM-1（r = 0.641、P < 0.001）、PCT（r = 0.540、P = 0.001）呈正相关，与血清hs-CRP无相关性（r = 0.269、P = 0.124）。

结论

肺炎患者血清sTREM-1升高，以重症患者升高更为显著，且其与PSI评分呈正相关；检测血清sTREM-1水平有助于早期诊断重症肺炎，且其特异性及敏感性高，均优于PCT和hs-CRP，有望成为新的早期诊断重症肺炎的生物标志物。

关键词: 可溶性髓样细胞触发受体-1, 重症肺炎, 早期诊断, 降钙素原, 超敏C-反应蛋白

Objective

To investigate the value of serum soluble myeloid cell triggered receptor-1 (sTREM-1) in the early diagnosis of severe pneumonia.

Methods

Total of 60 patients with pneumonia who were treated in The Second Hospital of Jilin University from June 2021 to December 2021 were incorporated in study group, including 40 severe cases (severe pneumonia group) and 20 mild cases (common pneumonia group). Another 15 physical examiner during the same period were selected as control group. All patients in study group were evaluated by the pneumonia severity index (PSI) score within 24 hours after admission. The immunoscattering turbidimetry, electrochemical luminescence and enzyme-linked immunosorbent assay (ELISA) were used to detect the levels of serum procalcitonin (PCT), hypersensitive C-reactive protein (hs-CRP) and sTREM-1, respectively. The levels of serum sTREM-1 in severe pneumonia group, common pneumonia group and control group within admission 24 hours were compared, and the levels of PCT, hs-CRP and PSI score in severe and common pneumonia group within admission 24 hours were compared, respectively. The correlation between serum sTREM-1 and hs-CRP and PSI score were analyzed by Pearson correlation analysis; the correlation between serum PCT and PSI score were analyzed by Spearson correlation analysis. The value of serum sTREM-1, PCT and hs-CRP in the early diagnosis of severe pneumonia were compared by the area under receiver operating characteristic curve (ROC) by MedCalc software.

Results

The levels of serum sTREM-1 in severe pneumonia group, common pneumonia group and healthy control group (4 864.81 ± 1 314.53 pg/ml, 1 144.58 ± 571.01 pg/ml, 509.11 ± 43.70 pg/ml) were significantly different (F = 109.292, P < 0.001), and the levels of serum sTREM-1 of severe pneumonia group was significantly higher than those of common pneumonia group and control group (t = 10.981, P < 0.001; t = 9.264, P < 0.001). The levels of serum PCT, hs-CRP and PSI score in severe pneumonia group were significantly higher than those in common pneumonia group (Z =-3.360, P = 0.001; t = 2.047, P = 0.048; t = 4.878, P < 0.001). The AUCs of serum sTREM-1, PCT and hs-CRP for diagnosis of severe pneumonia were 1.00, 0.86 and 0.68, respectively (95%CI: 1.0-1.00, 0.73-0.98, 0.51-0.86). When 2 916.92 pg/ml, 0.31 ng/ml and 32.14 mg/L were selected as the Cut-off values, respectively, Youden index was highest; the corresponding sensitivity were 100%, 85% and 85%, while the specificity were 100%, 81% and 50%, respectively. The AUC of sTREM-1 for diagnosis of severe pneumonia was significantly different from those of hs-CRP and PCT (Z = 3.463, P < 0.001; Z = 2.220, P = 0.026). And there was no significant difference between hs-CRP and PCT (Z = 1.454, P = 0.146). The PSI score was positively correlated with the serum sTREM-1 (r = 0.641, P < 0.001) and PCT (r = 0.540, P = 0.001). However, there was no correlation between PSI score and serum hs-CRP (r = 0.269, P = 0.124).

Conclusions

The level of serum sTREM-1 increased in pneumonia, especially in severe cases, which is positively correlated with PSI score. The detection of serum sTREM-1 is valuable for the early diagnosis of severe pneumonia, and its specificity and sensitivity are higher than those of PCT and hs-CRP. It is expected to become a new biomarker for early diagnosis of severe pneumonia.

Key words: Soluble myeloid cell trigger receptor-1, Severe pneumonia, Early diagnosis, Procalcitonin, Hypersensitive C-reactive protein

表1 重症肺炎组和普通肺炎组患者的一般特征

指标		重症肺炎组（40例）	普通肺炎组（20例）	统计量	P值
性别[例（%）]				χ² = 0.13	0.714
	男	22（55.0）	10（50.0）
	女	18（45.0）	10（50.0）
年龄（± s，岁）		67 ± 14	64 ± 5	t = 0.88	0.385
死亡[例（%）]		15（37.5）	0（0.0）	χ² = 10.00	0.002
辅助通气[例（%）]				χ² = 20.00	< 0.001
	有创	24（60.0）	0（0.0）
	无创	16（40.0）	20（100.0）
实验室指标（± s）
	PaO₂/FiO₂	185 ± 67	368 ± 71	t = 7.74	< 0.001
	白细胞计数（× 10⁹/L）	15.96 ± 8.25	8.18 ± 2.56	t = 3.53	< 0.001
PSI评分分级[例（%）]				χ² = 16.51	< 0.001
	Ⅰ级	0（0.0）	2（10.0）
	Ⅱ~Ⅲ级	13（32.5）	15（75.0）
	Ⅳ~Ⅴ级	27（67.5）	3（15.0）

表1 重症肺炎组和普通肺炎组患者的一般特征

指标		重症肺炎组（40例）	普通肺炎组（20例）	统计量	P值
性别[例（%）]				χ² = 0.13	0.714
	男	22（55.0）	10（50.0）
	女	18（45.0）	10（50.0）
年龄（± s，岁）		67 ± 14	64 ± 5	t = 0.88	0.385
死亡[例（%）]		15（37.5）	0（0.0）	χ² = 10.00	0.002
辅助通气[例（%）]				χ² = 20.00	< 0.001
	有创	24（60.0）	0（0.0）
	无创	16（40.0）	20（100.0）
实验室指标（± s）
	PaO₂/FiO₂	185 ± 67	368 ± 71	t = 7.74	< 0.001
	白细胞计数（× 10⁹/L）	15.96 ± 8.25	8.18 ± 2.56	t = 3.53	< 0.001
PSI评分分级[例（%）]				χ² = 16.51	< 0.001
	Ⅰ级	0（0.0）	2（10.0）
	Ⅱ~Ⅲ级	13（32.5）	15（75.0）
	Ⅳ~Ⅴ级	27（67.5）	3（15.0）

表2 各组研究对象血清指标和PSI评分

组别	例数	sTREM-1（± s，pg/ml）	PCT [M（P25，P75），ng/ml]	hs-CRP（± s，mg/L）	PSI评分（± s，分）
健康对照组	15	509.11 ± 43.70	—	—	—
普通肺炎组	20	1 144.58 ± 571.01	1.42（0.54，6.22）	31.54 ± 22.97	77 ± 20
重症肺炎组	40	4 864.81 ± 1 314.53	0.19（0.06，0.41）	46.50 ± 19.59	134 ± 39
统计量		F = 109.292	Z=－3.360	t = 2.047	t = 4.878
P值		< 0.001	0.001	0.048	< 0.001

表2 各组研究对象血清指标和PSI评分

组别	例数	sTREM-1（± s，pg/ml）	PCT [M（P25，P75），ng/ml]	hs-CRP（± s，mg/L）	PSI评分（± s，分）
健康对照组	15	509.11 ± 43.70	—	—	—
普通肺炎组	20	1 144.58 ± 571.01	1.42（0.54，6.22）	31.54 ± 22.97	77 ± 20
重症肺炎组	40	4 864.81 ± 1 314.53	0.19（0.06，0.41）	46.50 ± 19.59	134 ± 39
统计量		F = 109.292	Z=－3.360	t = 2.047	t = 4.878
P值		< 0.001	0.001	0.048	< 0.001

表3 血清sTREM-1、PCT和hs-CRP诊断重症肺炎的ROC曲线分析

指标	AUC	最佳阈值	敏感性（%）	特异性（%）	95%CI
sTREM-1	1.00	2 916.92 pg/ml	100	100	1.00~1.00
PCT	0.86	0.31 ng/ml	85	81	0.73~0.98
hs-CRP	0.68	32.14 mg/L	85	50	0.51~0.86

表3 血清sTREM-1、PCT和hs-CRP诊断重症肺炎的ROC曲线分析

指标	AUC	最佳阈值	敏感性（%）	特异性（%）	95%CI
sTREM-1	1.00	2 916.92 pg/ml	100	100	1.00~1.00
PCT	0.86	0.31 ng/ml	85	81	0.73~0.98
hs-CRP	0.68	32.14 mg/L	85	50	0.51~0.86

图1 血清sTREM-1、PCT和hs-CRP诊断重症肺炎的ROC曲线

图2 PSI评分与血清PCT、hs-CRP和sTREM-1的相关性注：A：PSI评分与PCT相关性；B：PSI评分与hs-CRP相关性；C：PSI评分与sTREM-1相关性

[1]	Nair GB, Niederman MS. Year in review 2013: Critical care--respiratory infections[J]. Crit Care,2014,18(5):572.
[2]	张娜，方春晓. 老年重症肺炎病原学特点以及预后相关因素分析[J]. 中国微生态学杂志,2019,31(9):1043-1046.
[3]	刘丹，秦垚，余珍燕. 病原学筛查及C-反应蛋白,降钙素原和白细胞介素-6在小儿下呼吸道感染诊断及疗效监测中的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2021,15(4):235-242.
[4]	Ruiz-González A, Esquerda A, Falguera M, et al. Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in community-acquired pneumonia[J]. Respirology,2011,16(2):321-325.
[5]	Michel CS, Teschner D, Wagner EM, et al. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation[J]. Ann Hematol,2017,96(12):2095-2101.
[6]	Cao C, Gu J, Zhang J. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases[J]. Front Med,2017,11(2):169-177.
[7]	Su L, Liu D, Chai W, et al. Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis[J]. BMJ Open,2016,6(5):e010314.
[8]	刘新光，崔玉娇，王毅, 等. 肺炎链球菌血流感染患儿的生存分析及mNAP, Presepsin, TREM-1水平的早期预测价值[J]. 医学动物防制,2021,37(9):830-833.
[9]	Yang ZQ, Mai JY, Zhu ML, et al. Soluble Triggering Receptors Expressed on Myeloid Cells-1 as a Neonatal Ventilator-Associated Pneumonia Biomarker[J]. Int J Gen Med,2021,14:4529-4534.
[10]	瞿介明，曹彬. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)修订要点[J]. 中华结核和呼吸杂志,2016,39(4):241-242.
[11]	Zhang ZX, Zhang W, Liu P, et al. Prognostic value of Pneumonia Severity Index, CURB-65, CRB-65, and procalcitonin in community-acquired pneumonia in Singapore[J]. Proc Singap Healthc,2016,25(3):139-147.
[12]	Martolini D, Pistella E, Carmenini E, et al. NT-proBNP correlates with the illness scores pneumonia severity index and CURB-65 in patients with pneumonia[J]. Ital J Med,2017,11(1):37-40.
[13]	Niederman MS, Alder J, Bassetti M, et al. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial[J]. Lancet Infect Dis,2020,20(3):330-340.
[14]	英媛媛，徐佳傲，丁雪, 等. 不同标本留取方法对细菌培养结果的影响[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(5):657-660.
[15]	文福生，张必旗，常佳军. 多指标联合检测在小儿细菌性肺炎病原学诊断中的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(5):418-423.
[16]	Falup-Pecurariu OG, Diez-Domingo J, Esposito S, et al. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations[J]. Eur J Pediatr,2018,177(7):1111-1120.
[17]	Ito A, Ishida T, Tachibana H, et al. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia[J]. Clin Chem Lab Med (CCLM),2019,57(10):1632-1637.
[18]	Póvoa P. C-reactive protein: a valuable marker of sepsis[J]. Intensive Care Med,2002,28(3):235-243.
[19]	Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response[J]. Biochem J,1990,265(3):621-636.
[20]	Ford J W, Mcvicar D W. TREM and TREM-like receptors in inflammation and disease[J]. Curr Opin Immunol,2009,21(1):38-46.
[21]	Feng JY, Su WJ, Chuang FY, et al. TREM-1 enhances Mycobacterium tuberculosis-induced inflammatory responses in macrophages[J]. Microbes Infect,2021,23(1):104765.
[22]	Coimbra R. sTREM-1 as a predictor of severity and outcome in acute pancreatitis: the magic bullet or just another inflammatory mediator?[J]. Crit Care Med,2008,36(7):2197-2198.
[23]	牛芳，张翠翠，唐素娟. sTREM-1, BNP, D-二聚体, PCT, IL-6在老年重症肺炎中的评估价值[J]. 临床肺科杂志,2021,26(8):1208-1211.
[24]	陈一洲，陈丹琦，叶勇健, 等. 炎症因子及sTREM-1水平对骨折患者术后感染的评估价值[J]. 健康研究,2021,41(1):74-77.
[25]	陈晓珊. 血清PCT, RAGE, sTREM-1表达水平与重症肺炎患者病情严重程度及预后的关系[J]. 标记免疫分析与临床,2020,27(1):136-141.
[26]	郭鑫鑫. 血浆sTREM-1, sFLT-1水平与重症肺炎APACHE Ⅱ评分的关联性[J]. 牡丹江医学院学报,2021,42(1):71-74.
[27]	李冀，黄奕江，吴海洪, 等. 可溶性髓样细胞触发受体1和降钙素原联合检测在重症社区获得性肺炎中的应用价值[J]. 海南医学,2017,28(11):1782-1785.
[28]	杨丹榕，张云娇，徐凌, 等. 以指南和肺炎严重程度指数为标准分层确立社区获得性肺炎患者住院指征的对照分析[J]. 中华结核和呼吸杂志,2008,31(8):628.

[1]	何淳诺, 田志敏, 李焕玺, 吴昊越, 庄凯鹏, 周胜虎, 张浩强. 小儿发育性髋关节发育不良诊治的研究进展[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 497-504.
[2]	张烈, 严一核, 杜洁瑜. 分泌型白细胞蛋白酶抑制因子对无创呼吸机治疗重症肺炎患者的预测效能[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 301-306.
[3]	徐保平, 彭怀文, 喻怀斌, 王晓涛. 新型冠状病毒肺炎继发糖尿病酮症酸中毒合并肝门静脉积气一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 250-255.
[4]	赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[5]	于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[6]	刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[7]	董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[8]	燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[9]	甘志新, 胡雍军, 肖晶, 胡明冬. 降钙素原在脓毒血症与肺部感染中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 663-666.
[10]	赵静, 范晔, 游雅婷, 陈慧, 王静, 张静. 虚拟支气管镜导航联合径向超声支气管镜在周围型肺癌中的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 524-528.
[11]	袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12]	赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[13]	王江波, 尹一鸣, 张冠群. 外周血生物标志物在阿尔茨海默病早期诊断中的价值[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 244-249.
[14]	沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[15]	闫诺, 邓伟, 张英霞, 贺丹阳, 樊宁. 泌尿系超声检查联合降钙素原对儿童高级别膀胱输尿管反流的诊断价值[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 149-154.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Clinical value of a new biomarker serum soluble myeloid cell triggered receptor-1 in early diagnosis of severe pneumonia

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Clinical value of a new biomarker serum soluble myeloid cell triggered receptor-1 in early diagnosis of severe pneumonia